scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0002-9343(86)80007-9 |
P698 | PubMed publication ID | 3092651 |
P2093 | author name string | G L Garay | |
J M Mahoney | |||
L D Waterbury | |||
T M Peak | |||
R G Cohn | |||
P2860 | cites work | Relationship between the prevention of rat gastric erosions and the inhibition of acid secretion by prostaglandins | Q39121843 |
Stimulation by intragastrically administered E2prostaglandins of human gastric mucus output | Q39682775 | ||
The effects of aspirin and other non-steroid anti-inflammatory/analgesic drugs on gastro-intestinal mucus glycoprotein biosynthesis in vivo: Relationship to ulcerogenic actions | Q40679012 | ||
Effect of prostaglandin E2 on the healing of gastric ulcers: a double-blind endoscopic trail | Q43715915 | ||
Stimulation of mucus and nonparietal cell secretion by the E2 prostaglandins | Q44088878 | ||
Prostaglandins--role in gastric mucosal cytoprotection. | Q53975204 | ||
Effect of prostaglandin 15 (R) 15 methyl-E2-methyl ester on the gastric mucosa in patients with peptic ulceration — An endoscopic and histological study | Q69751442 | ||
A new PGE1 analogue (CL115,574) III. Effects on gastric acid and mucus secretion in man | Q70630623 | ||
The effect of orally administered prostaglandins on gastric mucus secretion in the rat | Q70923133 | ||
Effects of prostaglandin E2, 16,16-dimethyl prostaglandin E2 and a prostaglandin endoperoxide analogue (U-46619) on gastric secretory volume, [H+] and mucus synthesis and secretion in the rat | Q70967777 | ||
P433 | issue | 2A | |
P304 | page(s) | 30-33 | |
P577 | publication date | 1986-08-01 | |
P1433 | published in | American Journal of Medicine | Q2842959 |
P1476 | title | Stimulatory effect of enprostil, an anti-ulcer prostaglandin, on gastric mucus secretion | |
P478 | volume | 81 |
Q39523347 | A US multicenter study of enprostil 35 micrograms twice daily for treatment of prepyloric, pyloric channel, and duodenal bulb ulcers. Enprostil Study Group |
Q33471279 | Enprostil. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of peptic ulcer disease |
Q38353541 | Histamine H2-receptor antagonists versus prostaglandins in the treatment of peptic ulcer disease |